Pub Date : 2024-05-01DOI: 10.1016/j.rmclc.2024.05.009
Francisca Silva-González
Frailty is a multidimensional state characterized by a decrease in physiological reserves and resistance to stressors. Its physical dimension is highly recognized and increases vulnerability for developing greater dependency and/or death. Patients with chronic respiratory diseases have a higher risk of developing frailty and among the risk factors are comorbidities, smoking, low levels of physical activity, exacerbations of their underlying pathology, recurrent hospitalizations, poor nutrition and polypharmacy. Frailty is a dynamic and modifiable process. Timely referral to pulmonary rehabilitation programs is one of the different treatments available. The present article describes fragility in chronic respiratory disease patients, and offers tools to evaluate and modify it.
{"title":"Fragilidad en pacientes con enfermedades respiratorias crónicas: ¿cómo modificarla?","authors":"Francisca Silva-González","doi":"10.1016/j.rmclc.2024.05.009","DOIUrl":"10.1016/j.rmclc.2024.05.009","url":null,"abstract":"<div><p>Frailty is a multidimensional state characterized by a decrease in physiological reserves and resistance to stressors. Its physical dimension is highly recognized and increases vulnerability for developing greater dependency and/or death. Patients with chronic respiratory diseases have a higher risk of developing frailty and among the risk factors are comorbidities, smoking, low levels of physical activity, exacerbations of their underlying pathology, recurrent hospitalizations, poor nutrition and polypharmacy. Frailty is a dynamic and modifiable process. Timely referral to pulmonary rehabilitation programs is one of the different treatments available. The present article describes fragility in chronic respiratory disease patients, and offers tools to evaluate and modify it.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 319-324"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000427/pdfft?md5=9cc5359e7ebdb72f107a8ddff71300ca&pid=1-s2.0-S0716864024000427-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.rmclc.2024.06.002
Francisco Miguel Escandell-Rico , Lucia Pérez-Fernández , José Martínez-Ribera
Introduction
Cytostatic drugs are classified as potentially dangerous to health when handled. Methotrexate is a cytostatic and immunosuppressive drug increasingly used in primary care for the treatment of various rheumatological and dermatological problems. Therefore, those workers, such as nurses, who may be exposed to these risks, as a consequence of their professional work must be observed.
Objectives
Describe the management and exposure of methotrexate in the primary care nursing team of Orihuela Health Department, Spain.
Methodology
It corresponds to a descriptive observational study, carried out in the period from April 1 to 25, 2023. An observation guide was applied during a direct visit with nursing and following the recommendations of the current protocols for the management and exposure to cytostatics. Sampling was non-probabilistic for convenience. The sample size was calculated based on the nursing staff by estimating a proportion considering 7 health care areas and 31 auxiliary offices. As an inclusion criterion, a minimum of one year's experience in the administration of medication in the units under study was taken into account.
Results
Of a total of 124 nurses who provide services in primary care at the Orihuela Health Department, a total of 66 nurses participated. The mean age was 37.34 (SD 12.66). Two groups of nurses were created according to basic health zones with inhabitants of more than 25,000 or less than 25,000. It was considered that the Health Planning of the Territory in the autonomous communities of the Information System defined by Royal Decree 137/1984 of 22, on basic health structures for the improvement of Primary Care. In the observation guide, the lowest values were obtained in the evaluation/information of the patient regarding the management and exposure of methotrexate in the nurses. All nurses in both groups successfully applied the 5 rights of medication administration (route, dose, time, patient, and medication) for the safe management of methotrexate.
Conclusion
The results obtained in our research highlight the need to describe the management and exposure of methotrexate in the nursing team and the relevance of seeking methods to improve knowledge and skills. In this sense, this study could, through the observation guide used, improve the management and exposure to methotrexate in the primary care nursing team and avoid unnecessary risks that can have serious consequences for nurses and patients.
{"title":"Exposición laboral a citostáticos en el equipo de enfermería de atención primaria","authors":"Francisco Miguel Escandell-Rico , Lucia Pérez-Fernández , José Martínez-Ribera","doi":"10.1016/j.rmclc.2024.06.002","DOIUrl":"10.1016/j.rmclc.2024.06.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Cytostatic drugs are classified as potentially dangerous to health when handled. Methotrexate is a cytostatic and immunosuppressive drug increasingly used in primary care for the treatment of various rheumatological and dermatological problems. Therefore, those workers, such as nurses, who may be exposed to these risks, as a consequence of their professional work must be observed.</p></div><div><h3>Objectives</h3><p>Describe the management and exposure of methotrexate in the primary care nursing team of Orihuela Health Department, Spain.</p></div><div><h3>Methodology</h3><p>It corresponds to a descriptive observational study, carried out in the period from April 1 to 25, 2023. An observation guide was applied during a direct visit with nursing and following the recommendations of the current protocols for the management and exposure to cytostatics. Sampling was non-probabilistic for convenience. The sample size was calculated based on the nursing staff by estimating a proportion considering 7 health care areas and 31 auxiliary offices. As an inclusion criterion, a minimum of one year's experience in the administration of medication in the units under study was taken into account.</p></div><div><h3>Results</h3><p>Of a total of 124 nurses who provide services in primary care at the Orihuela Health Department, a total of 66 nurses participated. The mean age was 37.34 (SD 12.66). Two groups of nurses were created according to basic health zones with inhabitants of more than 25,000 or less than 25,000. It was considered that the Health Planning of the Territory in the autonomous communities of the Information System defined by Royal Decree 137/1984 of 22, on basic health structures for the improvement of Primary Care. In the observation guide, the lowest values were obtained in the evaluation/information of the patient regarding the management and exposure of methotrexate in the nurses. All nurses in both groups successfully applied the 5 rights of medication administration (route, dose, time, patient, and medication) for the safe management of methotrexate.</p></div><div><h3>Conclusion</h3><p>The results obtained in our research highlight the need to describe the management and exposure of methotrexate in the nursing team and the relevance of seeking methods to improve knowledge and skills. In this sense, this study could, through the observation guide used, improve the management and exposure to methotrexate in the primary care nursing team and avoid unnecessary risks that can have serious consequences for nurses and patients.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 355-363"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000476/pdfft?md5=57b8e9cb6aee5d5b894977665ccf146c&pid=1-s2.0-S0716864024000476-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A regular circadian rest-activity pattern is essential for optimal health. Any disruption or irregularity can lead to alterations in circadian rhythms, which in turn can trigger cardiometabolic illnesses. This review presents an approach to the literature on the circadian rest-activity pattern and its association with cardiometabolic illnesses.
Method
Narrative review.
Results
Circadian rest-activity pattern alterations, such as lower stability, reduced robustness, and higher fragmentation of circadian rest-activity rhythms, may be detrimental to human health. Furthermore, objective methods such as wrist actigraphy, questionnaires, and sleep diaries, as well as “dim light melatonin onset” (DLMO), have been proposed as feasible methods to assess the circadian rest-activity pattern.
Conclusion
In medical practice, it is crucial to view the circadian rest-activity pattern as a clinical biomarker related to human health. Additionally, alterations in the circadian rest-activity pattern have been linked to cardiometabolic illnesses.
{"title":"Circadian rest-activity pattern and cardiometabolic illnesses","authors":"Mario Henríquez-Beltrán , Claudia Jeria , Eduardo Cruces-Andrews , Thalía Belmonte","doi":"10.1016/j.rmclc.2024.04.002","DOIUrl":"10.1016/j.rmclc.2024.04.002","url":null,"abstract":"<div><h3>Background</h3><p>A regular circadian rest-activity pattern is essential for optimal health. Any disruption or irregularity can lead to alterations in circadian rhythms, which in turn can trigger cardiometabolic illnesses. This review presents an approach to the literature on the circadian rest-activity pattern and its association with cardiometabolic illnesses.</p></div><div><h3>Method</h3><p>Narrative review.</p></div><div><h3>Results</h3><p>Circadian rest-activity pattern alterations, such as lower stability, reduced robustness, and higher fragmentation of circadian rest-activity rhythms, may be detrimental to human health. Furthermore, objective methods such as wrist actigraphy, questionnaires, and sleep diaries, as well as “dim light melatonin onset” (DLMO), have been proposed as feasible methods to assess the circadian rest-activity pattern.</p></div><div><h3>Conclusion</h3><p>In medical practice, it is crucial to view the circadian rest-activity pattern as a clinical biomarker related to human health. Additionally, alterations in the circadian rest-activity pattern have been linked to cardiometabolic illnesses.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 290-298"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000397/pdfft?md5=59aed268732afc10269ea8368a3f32f8&pid=1-s2.0-S0716864024000397-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.rmclc.2024.05.007
Cecilia V. Amigo
Respiratory illnesses are an important cause of morbidity and mortality. Lung cancer is the leading cause of cancer and the leading cause of cancer mortality. Worldwide, chronic obstructive pulmonary disease (COPD) is the third leading cause of death, after cardiovascular and neoplastic diseases. Fibrosing interstitial lung disease has maintained a progressive increase in incidence, with high mortality. This is how respiratory palliative care has acquired relevance in this area of medicine, improving not only quality of life, but also, as is the case with lung cancer, survival. The aim of this article is to demonstrate the need for respiratory palliative care in cancer and non-cancer lung disease, allowing for an earlier and more timely referral for our patients.
{"title":"Neumopaliativo: el cuidado paliativo en patología respiratoria","authors":"Cecilia V. Amigo","doi":"10.1016/j.rmclc.2024.05.007","DOIUrl":"10.1016/j.rmclc.2024.05.007","url":null,"abstract":"<div><p>Respiratory illnesses are an important cause of morbidity and mortality. Lung cancer is the leading cause of cancer and the leading cause of cancer mortality. Worldwide, chronic obstructive pulmonary disease (COPD) is the third leading cause of death, after cardiovascular and neoplastic diseases. Fibrosing interstitial lung disease has maintained a progressive increase in incidence, with high mortality. This is how respiratory palliative care has acquired relevance in this area of medicine, improving not only quality of life, but also, as is the case with lung cancer, survival. The aim of this article is to demonstrate the need for respiratory palliative care in cancer and non-cancer lung disease, allowing for an earlier and more timely referral for our patients.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 325-329"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000403/pdfft?md5=3019a3991a0bdaa9fba725b3b118ab73&pid=1-s2.0-S0716864024000403-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.rmclc.2024.07.007
Manuel Matías Ambiado-Lillo , Mariano Guillermo Blake
Introduction
The study of communicative cognitive functions in children has been a focus of interest over the decades, aiming to explain the intricate relationships between language and executive functions (EF).
Objective
To historically reconstruct the relationship between developmental language disorder (DLD) and executive functions (EF).
Method
A narrative review was conducted of articles addressing the association between executive functions and developmental language disorder/specific language impairment. The search was performed in the databases of the “American Speech-Language-Hearing Association” and “PubMed” using the following syntax: (((executive function) AND (developmental language disorder)) OR (executive function)) AND (specific language impairment), without considering publication year restrictions.
Conclusions
The convergence of evidence over the decades and the contemporary focus on EF provide a more comprehensive view of the relationship between DLD and executive skills. These conclusions not only enrich the understanding of the underlying processes of DLD but also have crucial implications for clinical practice.
引言数十年来,对儿童交际认知功能的研究一直是人们关注的焦点,其目的在于解释语言与执行功能(EF)之间错综复杂的关系。方法对有关执行功能与发育性语言障碍/特定语言障碍之间关系的文章进行了叙述性综述。在 "美国言语-语言-听力协会 "和 "PubMed "数据库中使用以下语法进行检索:((执行功能) AND (发育性语言障碍))或(执行功能)结论数十年来证据的汇聚和当代对 EF 的关注,为 DLD 与执行技能之间的关系提供了一个更全面的视角。这些结论不仅丰富了人们对 DLD 潜在过程的理解,而且对临床实践具有重要意义。
{"title":"Funciones ejecutivas: ¿cómo impactan en el trastorno del desarrollo del lenguaje? Una revisión narrativa","authors":"Manuel Matías Ambiado-Lillo , Mariano Guillermo Blake","doi":"10.1016/j.rmclc.2024.07.007","DOIUrl":"10.1016/j.rmclc.2024.07.007","url":null,"abstract":"<div><h3>Introduction</h3><p>The study of communicative cognitive functions in children has been a focus of interest over the decades, aiming to explain the intricate relationships between language and executive functions (EF).</p></div><div><h3>Objective</h3><p>To historically reconstruct the relationship between developmental language disorder (DLD) and executive functions (EF).</p></div><div><h3>Method</h3><p>A narrative review was conducted of articles addressing the association between executive functions and developmental language disorder/specific language impairment. The search was performed in the databases of the “American Speech-Language-Hearing Association” and “PubMed” using the following syntax: (((executive function) AND (developmental language disorder)) OR (executive function)) AND (specific language impairment), without considering publication year restrictions.</p></div><div><h3>Conclusions</h3><p>The convergence of evidence over the decades and the contemporary focus on EF provide a more comprehensive view of the relationship between DLD and executive skills. These conclusions not only enrich the understanding of the underlying processes of DLD but also have crucial implications for clinical practice.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 341-346"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000567/pdfft?md5=bcbd3f53f1af4579e8f7832796e3f546&pid=1-s2.0-S0716864024000567-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142011948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01DOI: 10.1016/j.rmclc.2024.05.011
Sergio V. Flores , Ángel Roco-Videla
{"title":"A más de sesenta años de la hipótesis del genotipo ahorrador","authors":"Sergio V. Flores , Ángel Roco-Videla","doi":"10.1016/j.rmclc.2024.05.011","DOIUrl":"10.1016/j.rmclc.2024.05.011","url":null,"abstract":"","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 3","pages":"Pages 374-375"},"PeriodicalIF":0.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000464/pdfft?md5=feb787f086ba43691813cfa345e45115&pid=1-s2.0-S0716864024000464-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142012940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Childhood emotional maltreatment (CEM) has been widely linked to later affective symptoms. What still remains inadequately understood are the potential nuanced differences in the consequences of childhood emotional abuse (CEM-A) versus childhood emotional neglect (CEM-N) and the implicated mechanisms. Research with non-Western, clinical samples also remains scarce. Thus, we examined the associations of CEM-A and CEM-N with later affective symptoms among Chinese male drug users and tested impulsivity and psychological resilience as potential mediators and moderators.
Method: Structural equation modeling analyses were conducted with survey data obtained from 239 Chinese male adult drug users who were in a rehabilitation center.
Results: The mediating rather than the moderating hypotheses were supported. CEM-A was found to be positively associated with subsequent depressive and anxious symptoms through a positive association with impulsivity. In contrast, CEM-N was positively associated only with subsequent depressive symptoms via a negative association with psychological resilience. In addition, CEM-A was also found to be directly associated with later depressive and anxious symptoms.
Conclusions: CEM may pose a threat to later affective well-being partly through contributing to intrapersonal vulnerabilities as well as compromising intrapersonal strengths. Differentiating CEM-A and CEM-N appears to be critical for revealing the understudied specificity and nuance that may be inherently within such effects. Drug use treatment services should sensitively attend to the affective sequelae of CEM. Interventions targeted at the modification of impulsivity and the facilitation of psychological resilience may be effective in diminishing the affective consequences of CEM among drug users. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
目的:童年情感虐待(CEM)与日后的情感症状有着广泛的联系。但人们对童年情感虐待(CEM-A)与童年情感忽视(CEM-N)在后果上可能存在的细微差别以及相关机制仍缺乏足够的了解。针对非西方临床样本的研究也仍然很少。因此,我们研究了CEM-A和CEM-N与中国男性吸毒者日后情感症状的关联,并测试了冲动性和心理复原力作为潜在中介和调节因素的作用:结果:CEM-A和CEM-N与中国男性吸毒者日后的情感症状之间存在中介关系,而不是调节关系:结果:支持中介假设而非调节假设。研究发现,CEM-A 与冲动性呈正相关,从而与随后出现的抑郁症状和焦虑症状呈正相关。与此相反,CEM-N 仅通过与心理复原力的负相关与后续抑郁症状呈正相关。此外,研究还发现 CEM-A 与日后的抑郁症状和焦虑症状直接相关:结论:CEM 可能会对日后的情感健康造成威胁,部分原因是它会导致个人内部的脆弱性,同时也会损害个人内部的优势。区分 CEM-A 和 CEM-N 似乎是揭示未被充分研究的特异性和细微差别的关键,这种影响可能是内在的。药物使用治疗服务应敏感地关注 CEM 的情感后遗症。以改变冲动性和促进心理复原力为目标的干预措施,可能会有效地减轻吸毒者CEM的情感后遗症。(PsycInfo Database Record (c) 2022 APA, 版权所有)。
{"title":"Childhood emotional maltreatment and subsequent affective symptoms among chinese male drug users: The roles of impulsivity and psychological resilience.","authors":"Hongjian Cao, Haoran Meng, Xiaomin Geng, Xinyi Lin, Yanfang Zhang, Lili Yan, Shixin Fang, Lei Zhu, Lulu Wu, Qinglu Wu, Hongyu Liu, Nan Zhou, Jintao Zhang","doi":"10.1037/tra0001283","DOIUrl":"10.1037/tra0001283","url":null,"abstract":"<p><strong>Objective: </strong>Childhood emotional maltreatment (CEM) has been widely linked to later affective symptoms. What still remains inadequately understood are the potential nuanced differences in the consequences of childhood emotional abuse (CEM-A) versus childhood emotional neglect (CEM-N) and the implicated mechanisms. Research with non-Western, clinical samples also remains scarce. Thus, we examined the associations of CEM-A and CEM-N with later affective symptoms among Chinese male drug users and tested impulsivity and psychological resilience as potential mediators and moderators.</p><p><strong>Method: </strong>Structural equation modeling analyses were conducted with survey data obtained from 239 Chinese male adult drug users who were in a rehabilitation center.</p><p><strong>Results: </strong>The mediating rather than the moderating hypotheses were supported. CEM-A was found to be positively associated with subsequent depressive and anxious symptoms through a positive association with impulsivity. In contrast, CEM-N was positively associated only with subsequent depressive symptoms via a negative association with psychological resilience. In addition, CEM-A was also found to be directly associated with later depressive and anxious symptoms.</p><p><strong>Conclusions: </strong>CEM may pose a threat to later affective well-being partly through contributing to intrapersonal vulnerabilities as well as compromising intrapersonal strengths. Differentiating CEM-A and CEM-N appears to be critical for revealing the understudied specificity and nuance that may be inherently within such effects. Drug use treatment services should sensitively attend to the affective sequelae of CEM. Interventions targeted at the modification of impulsivity and the facilitation of psychological resilience may be effective in diminishing the affective consequences of CEM among drug users. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"23 1","pages":"S152-S162"},"PeriodicalIF":6.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78211856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.rmclc.2024.02.001
Pablo A. Rojas , Benjamín García-Bloj , Enrique Elias , Fernando Marchant
Prostate cancer (PCa) is the most frequent cancer in men in Chile and ranks fourth with regards to mortality according to the latest Globocan 2022 statistics. The aim of this review is to clarify what methods exist for preventing PCa, as well as updating screening recommendations based on the latest available evidence. Numerous risk factors have been described for PCa, including non-modifiable factors such as age, race, and family history. In this context, PCa screening becomes more relevant. Despite certain controversy regarding the usefulness of prostate-specific antigen (PSA), screening has shown that it increases the diagnosis of PCa in early stages, reducing mortality by up to 30%. The object of this review is to comment on the known risk factors for PCa and the usefulness of PCa screening, considering the use of new tools such as magnetic resonance imaging in the diagnosis of the disease.
{"title":"Actualización en detección precoz del cáncer de próstata","authors":"Pablo A. Rojas , Benjamín García-Bloj , Enrique Elias , Fernando Marchant","doi":"10.1016/j.rmclc.2024.02.001","DOIUrl":"https://doi.org/10.1016/j.rmclc.2024.02.001","url":null,"abstract":"<div><p>Prostate cancer (PCa) is the most frequent cancer in men in Chile and ranks fourth with regards to mortality according to the latest Globocan 2022 statistics. The aim of this review is to clarify what methods exist for preventing PCa, as well as updating screening recommendations based on the latest available evidence. Numerous risk factors have been described for PCa, including non-modifiable factors such as age, race, and family history. In this context, PCa screening becomes more relevant. Despite certain controversy regarding the usefulness of prostate-specific antigen (PSA), screening has shown that it increases the diagnosis of PCa in early stages, reducing mortality by up to 30%. The object of this review is to comment on the known risk factors for PCa and the usefulness of PCa screening, considering the use of new tools such as magnetic resonance imaging in the diagnosis of the disease.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 2","pages":"Pages 88-94"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000142/pdfft?md5=768b6c02221fb0f29ef24cbd328ba11d&pid=1-s2.0-S0716864024000142-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140346985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.rmclc.2024.03.002
Jorge Gallardo E., Rocío Solervicens
Gallbladder cancer is a very rare disease in Europe and North America, reason why there is scarce scientific research about it. At the same time, it is very common throughout the Andean region of South America, especially in Chile which once had the highest incidence and mortality rates in the world. Women account for 75% of patients, with cases being strongly related to long standing cholelithiasis, as well as chronic infection. Gallbladder cancer rarely exists without cholelitiasis. It is also closely associated with obesity and a diet high in fat and sugar. It is more common in some native populations, especially the Mapuche population, frequently associated with a low socioeconomic level and less access to the health system. In Chile, the mortality rate decreased by more than 50% in the last 20 years. Prophylactic cholecystectomy in high-risk population, implemented as a national policy in Chile, is reducing incidence and mortality from this disease which, for a long time, was the leading cause of death by cancer in Chilean women. The objective of this article is to outline the epidemiological history of gallbladder cancer in the world and in Chile as well as describe the risk factors and measures for its prevention.
{"title":"Factores de riesgo y prevención en cáncer de vesícula","authors":"Jorge Gallardo E., Rocío Solervicens","doi":"10.1016/j.rmclc.2024.03.002","DOIUrl":"https://doi.org/10.1016/j.rmclc.2024.03.002","url":null,"abstract":"<div><p>Gallbladder cancer is a very rare disease in Europe and North America, reason why there is scarce scientific research about it. At the same time, it is very common throughout the Andean region of South America, especially in Chile which once had the highest incidence and mortality rates in the world. Women account for 75% of patients, with cases being strongly related to long standing cholelithiasis, as well as chronic infection. Gallbladder cancer rarely exists without cholelitiasis. It is also closely associated with obesity and a diet high in fat and sugar. It is more common in some native populations, especially the Mapuche population, frequently associated with a low socioeconomic level and less access to the health system. In Chile, the mortality rate decreased by more than 50% in the last 20 years. Prophylactic cholecystectomy in high-risk population, implemented as a national policy in Chile, is reducing incidence and mortality from this disease which, for a long time, was the leading cause of death by cancer in Chilean women. The objective of this article is to outline the epidemiological history of gallbladder cancer in the world and in Chile as well as describe the risk factors and measures for its prevention.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 2","pages":"Pages 117-124"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000178/pdfft?md5=6a43212f13eaae10ea2e296620f1f737&pid=1-s2.0-S0716864024000178-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140348169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.rmclc.2024.03.005
Martín Vidal C. , Suraj Samtani
Worldwide, lung cancer is the first cancer in incidence and mortality. The most common histological type is non-small cell lung cancer (NSCLC). At an early stage, resection is the standard curative treatment, but relapse is high, which could be explained by micrometastatic disease. Adjuvant and neoadjuvant chemotherapy have little benefit in disease-free survival and overall survival, which is why new strategies have been studied. Immune checkpoint inhibitors (ICI) act by increasing the surveillance of the immune system. They have been used for years in advanced stage NSCLC, however, new schemes in earlier stages, be it as adjuvant therapy, neoadjuvant therapy or both, have demonstrated an important benefit in the endpoints studied. This review aims to describe the biologic rationale of ICIs in early-stage NSCLC and discuss the selected trials and endpoints.
{"title":"Inhibidores del punto de control inmune en cáncer pulmonar de células no pequeñas en etapa temprana: ¿Nuevo estándar de tratamiento?","authors":"Martín Vidal C. , Suraj Samtani","doi":"10.1016/j.rmclc.2024.03.005","DOIUrl":"https://doi.org/10.1016/j.rmclc.2024.03.005","url":null,"abstract":"<div><p>Worldwide, lung cancer is the first cancer in incidence and mortality. The most common histological type is non-small cell lung cancer (NSCLC). At an early stage, resection is the standard curative treatment, but relapse is high, which could be explained by micrometastatic disease. Adjuvant and neoadjuvant chemotherapy have little benefit in disease-free survival and overall survival, which is why new strategies have been studied. Immune checkpoint inhibitors (ICI) act by increasing the surveillance of the immune system. They have been used for years in advanced stage NSCLC, however, new schemes in earlier stages, be it as adjuvant therapy, neoadjuvant therapy or both, have demonstrated an important benefit in the endpoints studied. This review aims to describe the biologic rationale of ICIs in early-stage NSCLC and discuss the selected trials and endpoints.</p></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"35 2","pages":"Pages 74-81"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0716864024000245/pdfft?md5=d803a6e65f4d2c5c46690fbcf5d520b0&pid=1-s2.0-S0716864024000245-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140347031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}